These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 18686364)

  • 1. [Genetic diagnosis and therapy of head and neck cancer].
    Otsuki N; Nibu K
    Gan To Kagaku Ryoho; 2008 Jul; 35(7):1126-31. PubMed ID: 18686364
    [No Abstract]   [Full Text] [Related]  

  • 2. Downregulation of TESTIN and its association with cancer history and a tendency toward poor survival in head and neck squamous cell carcinoma.
    Gunduz E; Gunduz M; Beder L; Nagatsuka H; Fukushima K; Sutcu R; Delibas N; Yamanaka N; Shimizu K; Nagai N
    Arch Otolaryngol Head Neck Surg; 2009 Mar; 135(3):254-60. PubMed ID: 19289703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Aspects of Head and Neck Cancer Therapy.
    Puram SV; Rocco JW
    Hematol Oncol Clin North Am; 2015 Dec; 29(6):971-92. PubMed ID: 26568543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy for head and neck cancer.
    Harrington KJ; Nutting CM; Pandha HS
    Cancer Metastasis Rev; 2005 Jan; 24(1):147-64. PubMed ID: 15785878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p27: tumor suppressor and oncogene ...?
    Kossatz U; Malek NP
    Cell Res; 2007 Oct; 17(10):832-3. PubMed ID: 17934492
    [No Abstract]   [Full Text] [Related]  

  • 6. [Aspirin against cylindromatosis? Molecular functions of the CYLD tumor suppressor].
    Funk JO
    Hautarzt; 2004 Mar; 55(3):327-8. PubMed ID: 15029443
    [No Abstract]   [Full Text] [Related]  

  • 7. Evolving 'omics' technologies for diagnostics of head and neck cancer.
    Nagaraj NS
    Brief Funct Genomic Proteomic; 2009 Jan; 8(1):49-59. PubMed ID: 19273537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gene therapy of tumors of the head and neck: clinical use of the p53 tumor suppressor gene].
    Grgić M
    Lijec Vjesn; 2000; 122(1-2):14-6. PubMed ID: 10916351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DeltaNp63 isoforms differentially regulate gene expression in squamous cell carcinoma: identification of Cox-2 as a novel p63 target.
    Boldrup L; Coates PJ; Gu X; Nylander K
    J Pathol; 2009 Aug; 218(4):428-36. PubMed ID: 19391123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of autophagy by oncogenes and tumor suppressor genes.
    Maiuri MC; Tasdemir E; Criollo A; Morselli E; Vicencio JM; Carnuccio R; Kroemer G
    Cell Death Differ; 2009 Jan; 16(1):87-93. PubMed ID: 18806760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity at the 9p21-24 region and identification of BRM as a candidate tumor suppressor gene in head and neck squamous cell carcinoma.
    Gunduz E; Gunduz M; Ali MA; Beder L; Tamamura R; Katase N; Tominaga S; Yamanaka N; Shimizu K; Nagatsuka H
    Cancer Invest; 2009 Jul; 27(6):661-8. PubMed ID: 19488910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [RNA extraction, in vitro translation and two-dimensional analysis of oncoproteins in cancers of the upper respiratory and digestive tracts].
    Bessède JP; Najid A; Coignoux Y; Sauvage JP; Rigaud M
    Rev Laryngol Otol Rhinol (Bord); 1992; 113(3):157-61. PubMed ID: 1344530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticancer activity and differentially expressed genes in head and neck cancer cells treated with a novel cyclin-dependent kinase inhibitor.
    Shin HC; Song DW; Baek WK; Lee SR; Kwon TK; Lee J; Park SH; Jang BC; Park JW
    Chemotherapy; 2009; 55(5):353-62. PubMed ID: 19657189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of Brooke-Spiegler syndrome with a new mutation in the CYLD gene.
    Heinritz W; Grunewald S; Strenge S; Schütz A; Froster UG; Glander HJ; Paasch U; Simon JC
    Br J Dermatol; 2006 May; 154(5):992-4. PubMed ID: 16634909
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of molecular markers and gene profiling in head and neck cancers.
    Gold KA; Kim ES
    Curr Opin Oncol; 2009 May; 21(3):206-11. PubMed ID: 19346943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxicity and antiangiogenesis by fibroblast growth factor 2-targeted Ad-TK cancer gene therapy.
    Saito K; Khan K; Sosnowski B; Li D; O'Malley BW
    Laryngoscope; 2009 Apr; 119(4):665-74. PubMed ID: 19213040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular markers in the head and neck cancers: are we there yet?
    Rath GK
    J Cancer Res Ther; 2013; 9(1):1-2. PubMed ID: 23575064
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetic profile of head and neck squamous cell carcinoma: clinical implications.
    Agada FO; Patmore H; Alhamarneh O; Stafford ND; Greenman J
    J Laryngol Otol; 2009 Mar; 123(3):266-72. PubMed ID: 18694533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of the microenvironment of head and neck cancers on tumor progression].
    Lukits J
    Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant p53 and cyclin A1 protein expression in primary laryngeal squamous cell carcinomas do not correlate to second primary tumours of the head and neck.
    Farhadieh RD; Smee R; Rees CG; Salardini A; Eggleton S; Yang JL; Russell PJ
    ANZ J Surg; 2009; 79(1-2):48-54. PubMed ID: 19183379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.